Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of Neurocrine Biosciences's NBI-1065846?
NBI-1065846 is a small molecule commercialized by Neurocrine Biosciences, with a leading Phase II program in Cognitive Impairment Associated With...